Literature DB >> 10807486

A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa.

W S Agras1, T Walsh, C G Fairburn, G T Wilson, H C Kraemer.   

Abstract

BACKGROUND: Research suggests that cognitive-behavioral therapy (CBT) is the most effective psychotherapeutic treatment for bulimia nervosa. One exception was a study that suggested that interpersonal psychotherapy (IPT) might be as effective as CBT, although slower to achieve its effects. The present study is designed to repeat this important comparison.
METHOD: Two hundred twenty patients meeting DSM-III-R criteria for bulimia nervosa were allocated at random to 19 sessions of either CBT or IPT conducted over a 20-week period and evaluated for 1 year after treatment in a multisite study.
RESULTS: Cognitive-behavioral therapy was significantly superior to IPT at the end of treatment in the percentage of participants recovered (29% [n=32] vs 6% [n=71), the percentage remitted (48% [n=53] vs 28% [n = 31]), and the percentage meeting community norms for eating attitudes and behaviors (41% [n=45] vs 27% [n=30]). For treatment completers, the percentage recovered was 45% (n= 29) for CBT and 8% (n= 5) for IPT. However, at follow-up, there were no significant differences between the 2 treatments: 26 (40%) CBT completers had recovered at follow-up compared with 17 (27%) IPT completers.
CONCLUSIONS: Cognitive-behavioral therapy was significantly more rapid in engendering improvement in patients with bulimia nervosa than IPT. This suggests that CBT should be considered the preferred psychotherapeutic treatment for bulimia nervosa.

Entities:  

Mesh:

Year:  2000        PMID: 10807486     DOI: 10.1001/archpsyc.57.5.459

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  94 in total

Review 1.  Extracts from "Clinical evidence": Bulimia nervosa.

Authors:  P J Hay; J Bacaltchuk
Journal:  BMJ       Date:  2001-07-07

2.  Can family-based treatment of anorexia nervosa be manualized?

Authors:  J Lock; D Le Grange
Journal:  J Psychother Pract Res       Date:  2001

3.  Convergence of scores on the interview and questionnaire versions of the Eating Disorder Examination: a meta-analytic review.

Authors:  Kelly C Berg; Carol B Peterson; Patricia Frazier; Scott J Crow
Journal:  Psychol Assess       Date:  2011-09

4.  How many therapists? Practical guidance on investigating therapist effects in randomized controlled trials for eating disorders.

Authors:  Doug Thompson; Fary Cachelin; Ruth H Striegel-Moore; Bruce Barton; Munyi Shea; G Terence Wilson
Journal:  Int J Eat Disord       Date:  2012-03-12       Impact factor: 4.861

5.  Interpersonal psychotherapy: principles and applications.

Authors:  John C Markowitz; Myrna M Weissman
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

6.  Cognitive-behavioral therapy for subthreshold bulimia nervosa: A case series.

Authors:  C B Peterson; K B Miller; M G Willer; J Ziesmer; N Durkin; A Arikian; S J Crow
Journal:  Eat Weight Disord       Date:  2011-09       Impact factor: 4.652

7.  From efficacy to effectiveness to broad implementation: Evolution of the Body Project.

Authors:  Carolyn B Becker; Eric Stice
Journal:  J Consult Clin Psychol       Date:  2017-08

Review 8.  The changing "weightscape" of bulimia nervosa.

Authors:  Cynthia M Bulik; Marsha D Marcus; Stephanie Zerwas; Michele D Levine; Maria La Via
Journal:  Am J Psychiatry       Date:  2012-10       Impact factor: 18.112

9.  Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: a two-site trial with 60-week follow-up.

Authors:  Christopher G Fairburn; Zafra Cooper; Helen A Doll; Marianne E O'Connor; Kristin Bohn; Deborah M Hawker; Jackie A Wales; Robert L Palmer
Journal:  Am J Psychiatry       Date:  2008-12-15       Impact factor: 18.112

10.  Predictors of response to cognitive behavioral treatment for bulimia nervosa delivered via telemedicine versus face-to-face.

Authors:  Sonia Marrone; James E Mitchell; Ross Crosby; Steve Wonderlich; Tami Jollie-Trottier
Journal:  Int J Eat Disord       Date:  2009-04       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.